<DOC>
	<DOCNO>NCT02217267</DOCNO>
	<brief_summary>The purpose study evaluate Long term outcome serial Lidocaine infusion compare placebo peripheral neuropathic pain patient acute stage ( le 6 month ) 3 month first time infusion</brief_summary>
	<brief_title>Long Term Outcome After Serial Lidocaine Infusion Peripheral Neuropathic Pain</brief_title>
	<detailed_description>Peripheral nerve injury may give rise severe long-lasting type pain often resistant treatment opioid , tricyclic antidepressant anticonvulsant . Lidocaine infusion one intractable neuropathic pain treatment . My hypothesis serial lidocaine infusion adequate pain control prevent chronic pain ( central sensitisation ) . Therefore , design prospective , randomised , double-blind , control study evaluate efficacy serial lidocaine infusion peripheral neuropathic pain compare placebo long term outcome ( 3 month ) .</detailed_description>
	<mesh_term>Neuralgia</mesh_term>
	<mesh_term>Peripheral Nervous System Diseases</mesh_term>
	<mesh_term>Lidocaine</mesh_term>
	<criteria>Peripheral neuropathic pain peripheral nerve injury within 6 month injury Well understand Thai language write listen Underlying Heart disease Arrhythmia Allergy lidocaine , Gabapentin , Carbamazepine , tramadol History epilepsy History lidocaine use Underlying Psychiatric disease History drug abuse Pregnancy nursing</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>August 2014</verification_date>
	<keyword>Peripheral neuropathy</keyword>
</DOC>